Illustrative image – not actual.Eisai Pharmaceuticals India’s capacity expansion of Active Pharmaceutical Ingredients’ (APIs) plant will be completed by the end of October 2017.
The API unit’s production capacity is being raised from 30 tpa to 100 tpa.
The unit is located at Visakhapatnam in Andhra Pradesh. The Japanese drug manufacturing company has made an investment of more than Rs 30 crore in expansion of the plant in addition to the investment made previously.
The company has so far, made an investment of Rs 300 crore in India, and has lined up another Rs 50 crore investment in the next two years.
The API unit’s production capacity is being raised from 30 tpa to 100 tpa.
The unit is located at Visakhapatnam in Andhra Pradesh. The Japanese drug manufacturing company has made an investment of more than Rs 30 crore in expansion of the plant in addition to the investment made previously.
The company has so far, made an investment of Rs 300 crore in India, and has lined up another Rs 50 crore investment in the next two years.
